Roundtable: Understanding the Standards & Regulatory Requirements for mRNA Cancer Vaccines
Moderator: Kun Zhuo

Time: 12:00 pm
day: Conference Day Two


  • How can we effectively show specificity and potency in mRNA cancer vaccines?
  • What are the best methods for testing potency in these vaccines and ensuring they are effective?
  • Which types of tumors are most responsive to this type of therapy, and how can we identify them?
  • Is it possible to start clinical trials with patients at an earlier diagnosis, and what are the potential implications of this approach?